Moors & Cabot’s Delek US DK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-9,083
Closed -$279K 883
2024
Q1
$279K Buy
+9,083
New +$246K 0.02% 697
2023
Q3
Sell
-12,591
Closed -$302K 838
2023
Q2
$302K Sell
12,591
-1,200
-9% -$27.3K 0.02% 611
2023
Q1
$317K Buy
13,791
+6,375
+86% +$160K 0.02% 585
2022
Q4
$200K Buy
+7,416
New +$219K 0.01% 742
2020
Q3
Sell
-15,325
Closed -$267K 717
2020
Q2
$267K Buy
15,325
+4,597
+43% +$87.7K 0.03% 480
2020
Q1
$171K Buy
10,728
+4,143
+63% +$98.2K 0.02% 516
2019
Q4
$222K Sell
6,585
-690
-9% -$24.9K 0.02% 535
2019
Q3
$263K Buy
7,275
+735
+11% +$27.1K 0.03% 480
2019
Q2
$262K Sell
6,540
-835
-11% -$30.6K 0.03% 445
2019
Q1
$270K Buy
+7,375
New +$251K 0.04% 419

Other funds holding DK

Moors & Cabot's DK Position: Q2 2024 in Review

Moors & Cabot sold out of Delek US (DK) in Q2 2024, closing a stake of 9,083 shares — an estimated $279K sold.

Moors & Cabot first reported a position in DK in Q1 2019 and held it in 10 quarters. The position peaked at $317K in Q1 2023. 226 funds tracked by Wall St. Rank hold DK as of Q2 2024.

  • Moors & Cabot reported no remaining Delek US position as of Q2 2024 after selling out during the quarter.
  • Moors & Cabot sold 9,083 Delek US shares in Q2 2024, an estimated $279K.
  • Moors & Cabot first reported a position in Delek US in Q1 2019 and held it in 10 quarters.
  • Moors & Cabot's Delek US position peaked at $317K in Q1 2023.
  • 226 funds tracked by Wall St. Rank held Delek US as of Q2 2024.

Based on Moors & Cabot's 13F filing for Q2 2024, filed 9 Aug 2024.